Puncture of the spinal canal and examination of cerebrospinal fluid dynamics and increased protein content are important for the early diagnosis of intraspinal tumors. When there is a suspicion of intraspinal tumor, the Quincke test and cerebrospinal fluid examination should be performed as soon as possible. Routine serial examinations of cerebrospinal fluid in patients with intraspinal tumors can show increased cerebrospinal fluid protein content with normal cell count, and dynamic examination (i.e., Quincke test) can show partial or complete obstruction.
First, X-ray film examination:About 30% to 40% of patients can be seen with bone changes. On routine anteroposterior and lateral X-ray films and oblique films, common signs include:
1. Expanding or destroying intervertebral foramina;
2. Spinal canal expansion, manifested as widening of the pedicle distance;
3. Bone changes of the vertebral bodies and appendages, such as vertebral body bone defects, destruction of pedicle roots, and so on;
4. Intraspinal calcification, occasionally seen in a few neurinomas, teratomas, and hemangioblastomas;
5. Paravertebral soft tissue shadow. Since most intraspinal tumors are benign, there is often no bone abnormality on the X-ray film in the early stage, and sometimes only indirect signs such as widening of the pedicle distance, thinning of the cortical bone of the spinal canal wall, and expansion of the spinal canal can be seen in the late stage. For dumbbell-shaped vertebral bodies and other intraspinal tumors, there can be widening of the intervertebral foramen. X-ray film examination can exclude symptoms of spinal cord compression caused by spinal deformity, tumor, and other reasons, and is still an indispensable routine examination.
Second, myelography:It is one of the effective methods for showing intraspinal space-occupying lesions, and iodine oil or iodine water contrast agent can be used for cervical spinal canal myelography, especially when the drug is injected into the cisterna magna, it is easy to make a diagnosis. It shows that the contrast agent appears as a cup-shaped defect or blockage on the non-intervertebral disc plane. Literature reports 180 cases of neurilemmoma, among which 150 cases showed: 106 cases with cup-shaped filling defect, 18 cases with horizontal cross-sectional shape, 7 cases with oblique needle-like shape, 5 cases with bell-shaped, and 4 cases with bead-like. OMNIPAQUE is the second-generation non-ionic iodine water-soluble contrast agent, with clear imaging, safety, and reliability. It can determine spinal cord tumors according to the expansion, displacement, and subarachnoid obstruction of the spinal cord, and combined with increased cerebrospinal fluid protein, make an accurate diagnosis. Due to adhesions and other reasons, the obstruction plane is not necessarily representative of the true boundary of the tumor. Ni Bin et al. reported that in 137 cases of intraspinal tumors, 4 cases had an obstruction plane that differed from the surgical exploration results by 1/4 to 1 vertebral body. Unless a second myelography is performed, a single myelography can only determine the upper or lower limit of the tumor, and it cannot determine the nature of the tumor solely based on the obstruction shape and bone involvement. However, myelography can determine the location of the lesion, and then perform CT scanning or MRI examination to obtain more information about the tumor lesions.
Three, CT examination:CT scanning has sensitive density resolution and can clearly display the tissue structures such as the spinal cord and nerve roots in cross-sections. It can clearly show the soft tissue shadow of the tumor, which is helpful for the diagnosis of intraspinal tumors, which is not available in traditional imaging methods. However, the location of CT scanning, especially when it is used as the first imaging examination, needs to be determined according to clinical signs. There is a possibility of missing the tumor location due to inaccurate localization. CT can basically determine the segmental distribution and lesion range of intraspinal tumors, but it is difficult to distinguish them from the normal spinal cord substance. CTM can show the entire relationship between the spinal cord and the tumor and distinguish between intramedullary tumors and spinal cord cysts.
Four, MRI:Magnetic Resonance Imaging (MRI) is an ideal examination method with no side effects of ionizing radiation. It can observe the spinal cord in three dimensions and display the boundary between tumor tissue and normal tissue, the location, size, and extent of the tumor, and directly outline the tumor, showing its longitudinal and transverse extension and its relationship with surrounding tissue structures. It has become the preferred method for diagnosing spinal cord tumors. MRI has its advantages in distinguishing intramedullary and extramedullary tumors. The MRI imaging of intramedullary tumors shows the expansion of the spinal cord in this area, with different signal intensities displayed by the tumor in different pulse sequences, which can be distinguished from syringomyelia. Extramedullary tumors can be localized according to their relationship with the dura mater, with a high accuracy rate. Sagittal MRI imaging shows the tumor as a clear, long T1, long T2 signal area, but mainly long T1, with a significant enhancement effect, and some show cystic changes. Axial imaging shows the cervical spinal cord being compressed to one side, with the tumor appearing elliptical or crescent-shaped. For dumbbell-shaped tumors that protrude outward through intervertebral foramina, the continuity of intraspinal and extraspinal masses can be seen. Since MRI directly performs sagittal imaging, the range of spinal cord examination is larger than that of CT scanning, which is unparalleled by CT. Moreover, MRI can show the size, location, and tissue density of the tumor, especially the application of paramagnetic contrast agent GD-DTPA can clearly show the outline of the tumor, so MRI is very important for diagnosis and surgical localization, which is far inferior to MRI in terms of CT or CTM.